ACR: TNF inhibitors linked to reduced risk of ACS in RA
(HealthDay)—For patients with rheumatoid arthritis (RA), tumor necrosis factor inhibitor (TNFi) treatment correlates with reductions in the risk of acute coronary syndromes (ACS) and myocardial infarction (MI), according ...
Oct 29, 2013
0
0